Where is the live CopyMark page for USPTO serial 90584106?

The live record is at https://getcopymark.com/trademark/90584106. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns RARE REVOLUTION?

According to the public USPTO record for serial number 90584106, the listed owner(s) include: Shepherd Therapeutics, LLC, Shepherd Therapeutics, LLC.

What is USPTO serial number 90584106?

Serial number 90584106 is the USPTO application identifier for the mark RARE REVOLUTION. It is used to track examination, publication, and registration of this trademark.

What is the current status of RARE REVOLUTION?

RARE REVOLUTION (90584106) currently shows USPTO status code 605 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover RARE REVOLUTION?

The public record lists International Classes: 005, 009, 025, 035, 036, 041, 042, 044, 045. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: RARE REVOLUTION Serial# 90584106 | status 605; last event MAB5 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RARE REVOLUTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

BRIAN J. FOCARINO COOLEY LLP1299 PENNSYLVANIA AVENUE, N.W.SUITE 700WASHINGTON, DC 20004

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of cancer; medicines for human purposes, namely, for treating genetically based diseases and disorders	ABANDONED	—
009	Downloadable podcasts in the field of promoting public interest and awareness of rare diseases; downloadable computer software in the nature of a mobile application to promote public interest and awareness of rare diseases; downloadable computer software for sharing, transmitting, storing, uploading, downloading, sending, and receiving information concerning rare diseases	ABANDONED	—
025	Apparel, namely, tee shirts, sweatshirts, pants, leggings, shorts, jackets, hats and caps being headwear; footwear	ABANDONED	—
035	Promoting collaboration within the scientific, research, medical, and business communities to achieve advances in the field of healthcare; promoting collaboration within the scientific, research, medical provider, and business communities to achieve advances in the field of rare diseases; marketing campaign services in the nature of promoting public awareness among rare disease patients, caregivers, families, advocates, and friends; online retail store services featuring apparel and footwear; promoting public awareness of rare diseases and cancers by means of public advocacy; advertising and marketing consultancy; advertising, promotion, and marketing services in the nature of using social and digital media technology to find patients for medical providers and to connect patients to clinical studies; marketing consultation in the field of clinical trials; marketing consulting, namely, developing and monitoring social and digital media advertising campaigns in connection with clinical trials and patients with rare medical conditions; marketing services in the nature of conducting online, phone or in-person patient or physician market research; on-line advertising and marketing services; providing demand creation and lead generation activities and services; providing marketing consulting in the field of social media; business consulting and business management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and business management in the field of clinical trials, namely, providing information management services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs	ABANDONED	—
036	Charitable fundraising services for promoting research, education and other activities relating to cancers and other rare diseases; venture capital services, namely, providing financing to emerging and start-up companies; hedge fund investment services; private equity fund investment services; financial analysis; financial planning and investment advisory service; insurance brokerage in the field of medical and health insurance; providing information in the field of finance and the financial aspects of medical and health procedures, treatments, and insurance	ABANDONED	—
041	Arranging, organizing, conducting, and hosting social entertainment events; entertainment, namely, live musical performances; organizing cultural and arts events	ABANDONED	—
042	Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials for others; basic and clinical research in the field of health care and medicine; Clinical and medical research, data collection and scientific analysis for the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease; operating, namely, creating and hosting an online community website relating to patients with rare diseases; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels; design and development of computer software; platform as a service (PAAS) featuring computer software platforms for clinical trial patient lead management and enrollment; Platform as a service (PAAS) featuring computer software platforms for clinical trials; Platform as a service (PAAS) featuring computer software platforms for patient and physician market research; Platform as a service (PAAS) featuring computer software platforms for education about rare diseases and treatment received	ABANDONED	—
044	Health care services, namely, cancer therapy; providing a web site featuring medical information; providing a website featuring information in the field of the diagnosis and treatment of rare diseases; providing a website featuring information in the field of rare disease health; providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing medical information to patients in the form of reports in the field of medicine and rare diseases; providing news and information in the field of medicine; providing educational information about healthcare	ABANDONED	—
045	Online social networking services for patient and caregiver communities	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 28, 2021	MAB5	ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION	—
Dec 28, 2021	ABN5	ABANDONMENT - AFTER PUBLICATION	—
Dec 20, 2021	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Nov 23, 2021	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Nov 23, 2021	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 3, 2021	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Oct 21, 2021	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 20, 2021	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Oct 20, 2021	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Oct 20, 2021	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Oct 20, 2021	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Oct 19, 2021	DOCK	ASSIGNED TO EXAMINER	—
Jun 17, 2021	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Mar 20, 2021	NWAP	NEW APPLICATION ENTERED	—

RARE REVOLUTION